Summary
- Current Price
- As of today, TLX price is $9.13, down -1.19% on
- Current Price All-Time High
- TLX price is currently -69.93% below its historical high of $30.36 set on
- Market Cap
- TLX current market cap is $3B, down -43.68% year-over-year
- PE Ratio
- TLX PE ratio is unknown
- Revenue
- TLX current annual revenue is $804.64M, up +55.76% year-over-year
- Next Earnings
- As of today, the next earnings release for TLX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Telix Pharmaceuticals Limited |
| Ticker | NASDAQ: TLX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | telixpharma.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.13 | |
| Price, 1D Change | -1.19% | |
| $3B | ||
| - | ||
| - | ||
| 0.99 | ||
| $805M | ||
| Revenue, 1Y Change | +55.76% | |
| -$0.02 | ||
| EPS, 1Y Change | -122.12% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.02 | ||
| EPS Estimate | N/A | $0.11 |
| EPS Est. Change | N/A | +599.05% |
| $804.64M | ||
| Revenue Estimate | N/A | $1.36B |
| Revenue Est. Change | N/A | +68.78% |
| Current Price | $9.13 | |
| Price Target | - | $20.97 |
| Price Tgt. Change | - | +129.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.19 | $0.10 | -50.54% | |
| $0.02 | -$0.02 | -240.67% | |
| $0.11 | N/A | +599.05% | |
| $0.38 | N/A | +1,890.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $779.38M | $516.60M | -33.72% | |
| $1.23B | $804.64M | -34.64% | |
| $1.36B | N/A | +68.78% | |
| $1.60B | N/A | +98.61% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.13 | |
| $10.16 | ||
| SMA 200 vs Price | +11.24% | |
| $7.70 | ||
| SMA 50 vs Price | -15.70% | |
| 0.99 | ||
| $0.38 | ||
| 61.48 | ||
| 55.47% | ||
| 61.39% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $804.64M | ||
| -$0.02 | ||
| $427.36M | ||
| 53.11% | ||
| $17.78M | ||
| 2.21% | ||
| -$7.13M | ||
| -0.89% | ||
| $39.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.12 | ||
| 1.43 | ||
| 1.27 | ||
| - | ||
| - | ||
| 3.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -17.22 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $415.38M | ||
| $141.87M | ||
| $1.18B | ||
| $330.28M | ||
| $766.73M | ||
| $231.62M | ||
| $467.11M | ||
| $18.66M | ||
| $71.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $811.77M | ||
| $409.58M | ||
| $377.28M | ||
| $192.76M | ||
| $21.43M | ||
| $0.00 | ||
| $1.86M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$17.31M | ||
| -$286.22M | ||
| -$3.72M | ||
| $56.06M | ||
| -$73.37M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| Citigroup | ||
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | ||
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with TLX
FAQ
What is the ticker symbol for Telix Pharmaceuticals Limited?
The ticker symbol for Telix Pharmaceuticals Limited is NASDAQ:TLX
Does Telix Pharmaceuticals Limited pay dividends?
No, Telix Pharmaceuticals Limited does not pay dividends
What sector is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited is in the Healthcare sector
What industry is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited is in the Biotechnology industry
What country is Telix Pharmaceuticals Limited based in?
Telix Pharmaceuticals Limited is headquartered in Australia
When did Telix Pharmaceuticals Limited go public?
Telix Pharmaceuticals Limited initial public offering (IPO) was on November 14, 2024
Is Telix Pharmaceuticals Limited in the S&P 500?
No, Telix Pharmaceuticals Limited is not included in the S&P 500 index
Is Telix Pharmaceuticals Limited in the NASDAQ 100?
No, Telix Pharmaceuticals Limited is not included in the NASDAQ 100 index
Is Telix Pharmaceuticals Limited in the Dow Jones?
No, Telix Pharmaceuticals Limited is not included in the Dow Jones index
When was Telix Pharmaceuticals Limited last earnings report?
Telix Pharmaceuticals Limited's most recent earnings report was on August 21, 2025
When does Telix Pharmaceuticals Limited report earnings?
The date for Telix Pharmaceuticals Limited's next earnings report has not been announced yet
Data Sources & References
- TLX Official Website telixpharma.com
- TLX Profile on Yahoo Finance finance.yahoo.com/quote/TLX
- TLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tlx